• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
SUN Jing,WAMG Xiaobing,GUO Dongxiao,WANG Guojin,LIU Wenkun,CHENG Chunlei.Research on the efficiency evaluation of drug risk monitoring and sampling inspection based on risk identification[J].Journal Of Pharmaceutical Research,2026,45(3):346-349[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2443times   Download 868次 QR Code for this article
Scan with your phone!
基于风险识别的药品风险监测抽检效能评价研究
孙晶,王小兵,郭东晓,王国金,刘文坤,程春雷
Font:Larger+|Default|Smaller-
(山东省食品药品检验研究院,产业技术基础公共服务平台,山东 济南 250101)
摘要:
摘要:目的 评价风险监测抽检风险识别效能,为提高药品质量抽检质效提供借鉴。方法 梳理2021—2023年药品抽检数据,分析评价抽检、监督抽检和风险监测抽检风险发现率,以及风险监测探索性研究发现的风险问题和企业确认情况等。结果 风险监测抽检的风险问题发现率为1.39%,远高于监督抽检(0.34%)和评价抽检(0.02%),中成药风险问题发现率最高。风险问题的企业验证结果重现率为78.1%,企业确认数逐年升高,平均查实率为75.2%,企业对探索性研究结果的认可率逐年升高。结论 风险监测抽检风险识别效能高,能够实现对药品潜在风险隐患的早发现、早防范、早排除,弥补了常规抽检的不足,是质量抽检体系的有效补充。
关键词:  风险识别  药品抽检  风险监测抽检  效能评价
DOI:10.13506/j.cnki.jpr.2026.03.015
基金项目:山东省卫生健康委员会山东省“十五五”卫生健康规划研究课题
Research on the efficiency evaluation of drug risk monitoring and sampling inspection based on risk identification
SUN Jing,WAMG Xiaobing,GUO Dongxiao,WANG Guojin,LIU Wenkun,CHENG Chunlei
()
Abstract:
Abstract:Objective To evaluate the risk identification efficiency of risk monitoring sampling and provide reference for improving the quality and efficiency of drug quality sampling.Methods Data drug sampling inspections during 2021—2023 were sorted out to analyze and evaluate the risk detection rates of evaluation sampling, supervisory sampling, and risk monitoring sampling, as well as risk issues identified through exploratory research in risk monitoring and enterprise confirmation status.Results The risk issue detection rate of risk monitoring sampling was 1.39%, significantly higher than that of supervisory sampling (0.34%) and evaluation sampling (0.02%), with traditional Chinese patent medicines having the highest risk issue detection rate. The reproducibility rate of enterprise re-test results for risk issues was 78.1%, the number of enterprise confirmations increased annually, the average verification rate was 75.2%, and enterprises' recognition rate of exploratory research results increased year by year.Conclusion Risk monitoring sampling demonstrates high risk identification efficiency, enabling early detection, prevention, and elimination of potential drug risks, making up for the shortcomings of routine sampling and serving as an effective supplement to the quality sampling system.
Key words:  Drug sampling  Risk monitoring  Risk identification  Efficiency evaluation
Today's Visits:487    Total Visits:2383201
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.